Algatech was founded in 1999 to develop and commercialize Astaxanthin and other microalgae-derived products for the nutraceuticals and cosmeceuticals industry. This mission was led by Algatech’s first nutraceutical product development, astaxanthin, and the company was established with the JCA’s backing to commercialize the work of Prof. Sammy Boussiba from the Sde Boker research institute of Ben-Gurion University of the Negev.

Astaxanthin is an important naturally occurring molecule and the most abundant carotenoid in the marine world. For more than ten years, astaxanthin’s role in enhancing the immune system and preventing oxidative stress has been the subject of international research both in universities and commercial enterprises. There are more than 300 publications and patents regarding astaxanthin. For a review describing the immense potential of astaxanthin, click here